Furthermore, we evaluated the therapeutic efficacy of LGG treatment against a murine chronic 3-cycle DSS-induced colitis and a T cell transfer colitis induced by transferring naive CD4+ T cells into Rag1-KO mice and found that LGG treatment significantly improved weight loss in both two colitis models (Supplemental Figure 1, C and D). The gene discussed is RAG1; the disease is colitis.